We are committed to research and development as one of the axes of the growth strategy (5% of sales) and with the commitment to offer a wide range of products with added value, from prescription products that address unmet needs, to products over-the-counter (OTC) and nutritional supplements for health maintenance.

We have a development pipeline balanced over time: in the short, medium and long term and in the value proposition with incremental innovation developments and more disruptive developments.

We are structured in 3 business units: